U.S. direct-to-consumer lab testing was valued at $1.5 billion in 2024 and is expected to more than double over the next decade. Yet as advanced biomarker testing grows in popularity, ...

Genetic testing has shifted from academic laboratories with expertise in specific genes to commercial laboratories that offer tests of a diverse array of genes. The purpose of this comparative study ...